---
title: "OKYO.US (OKYO.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/OKYO.US/news.md"
symbol: "OKYO.US"
name: "OKYO.US"
parent: "https://longbridge.com/zh-HK/quote/OKYO.US.md"
datetime: "2026-03-12T07:32:27.197Z"
locales:
  - [en](https://longbridge.com/en/quote/OKYO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OKYO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OKYO.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/OKYO.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/OKYO.US/news.md)


# OKYO.US (OKYO.US) — 相關新聞

### [OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress | OKYO Stock News](https://longbridge.com/zh-HK/news/276623142.md)
*2026-02-23T08:00:00.000Z*
> OKYO Pharma Limited announced that its abstract has been accepted for presentation at the ARVO 2026 Annual Meeting. Chie

### [OKYO Pharma (NASDAQ:OKYO) Raised to "Strong-Buy" at Piper Sandler](https://longbridge.com/zh-HK/news/276511952.md)
*2026-02-21T11:33:15.000Z*
> Piper Sandler upgraded OKYO Pharma (NASDAQ:OKYO) to a "strong-buy" rating. Other analysts have mixed views, with HC Wain

### [This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday](https://longbridge.com/zh-HK/news/276467088.md)
*2026-02-20T16:49:37.000Z*
> Top Wall Street analysts have initiated coverage on several companies. Baird's David Koning rated Affirm Holdings (AFRM)

### [OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of "Hold" by Brokerages](https://longbridge.com/zh-HK/news/276446108.md)
*2026-02-20T13:24:23.000Z*
> Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) have received a consensus rating of "Hold" from five brokerage

### [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://longbridge.com/zh-HK/news/276441716.md)
*2026-02-20T12:05:47.000Z*
> In Friday's pre-market session, Cardio Diagnostics Holdings (CDIO) led gainers with a 19.6% increase to $2.68, followed 

### [OKYO Pharma Prices $20 Million Underwritten Share Offering to Fund Clinical Development](https://longbridge.com/zh-HK/news/275915171.md)
*2026-02-13T14:28:22.000Z*
> OKYO Pharma Limited has announced a $20 million underwritten public offering of 10,815,000 ordinary shares at $1.85 per 

### [OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares | OKYO Stock News](https://longbridge.com/zh-HK/news/275843864.md)
*2026-02-12T19:20:00.000Z*
> OKYO Pharma Limited has announced the pricing of a public offering of 10,815,000 ordinary shares at $1.85 per share, aim